
Tennessee plans to execute inmate amid concerns his heart implant will shock him repeatedly
The device – an implantable cardioverter-defibrillator, or ICD – is at the center of a court battle that has been unfolding for several weeks. Black's attorneys want the device deactivated at or immediately before his lethal injection Tuesday morning.
If it isn't, they say the effects of the lethal injection drugs will cause the ICD to shock Black's heart, perhaps repeatedly, in an attempt to restore it to a normal rhythm. This will cause Black a prolonged and torturous execution, the attorneys argue, violating Eighth Amendment protections against cruel and unusual punishment.
'I don't want him to suffer. I do not want him tortured,' said Kelley Henry, one of Black's attorneys and the chief of the capital habeas unit for the Federal Public Defender based in Nashville. She described her 69-year-old client's case as the 'first of its kind.'
The case illustrates the complex ethical and practical dilemmas that emerge when medicine and capital punishment intersect. The American Medical Association's Code of Medical Ethics says physicians 'must not participate in a legally authorized execution,' because their profession calls on them to preserve life.
Indeed, Tennessee officials have indicated in court filings they do not have a medical professional available to turn off the implant after staff at a Nashville hospital refused to participate. They have also argued Black will not suffer, saying he would be unconscious if the ICD was activated and unable to perceive pain, according to The Associated Press.
On Friday, Black's attorneys said they appealed to the US Supreme Court, asking the justices to halt his execution after the Tennessee Supreme Court ruled Black's execution could proceed without deactivating his ICD.
'The ICD issue was never about a stay of execution,' Henry told CNN, but about securing a plan with state officials to prevent Black from suffering a torturous death if his execution proceeds. 'When you get a client with an actual execution date that could go forward, you have to start looking at his end of life, and what are the issues you need to raise to protect him.'
Reached for comment, the Tennessee Department of Correction referred CNN to the office of Attorney General Jonathan Skrmetti. In a statement, Skrmetti, a Republican, noted testimony from the state's experts 'refutes the suggestion that Black would suffer severe pain if executed.'
'Thirty-seven years have passed since Black brutally murdered six-year-old Lakeisha Clay, nine-year-old Latoya Clay, and their mother Angela Clay,' Skrmetti said, adding courts have repeatedly denied Black's other appeals.
'Our office will continue fighting to seek justice for the Clay family and to hold Black accountable for his horrific crimes,' Skrmetti said.
Black was convicted and sentenced to death for the 1988 murders of his then-girlfriend, Angela Clay, and her two daughters, Latoya and Lakeisha.
At the time, Clay was separated from her husband and the girls' father, according to a summary of the crime included in a Tennessee Supreme Court ruling. About 15 months before the killings, court records say, Black and Clay's husband were in an altercation in which Black shot the man, who survived. Black was sentenced to two years in the Davidson County Metropolitan Workhouse, with weekend furloughs.
Prosecutors accused Black of murdering Clay and her girls early on the morning of March 28, 1988, while he was out on furlough. All three victims were found dead in their apartment around 9:30 p.m. that day, each with gunshot wounds.
At trial, a firearms expert for the Tennessee Bureau of Investigation testified bullets recovered from the scene of the murders matched those recovered from Black's earlier shooting of Clay's husband. The .44 caliber bullets found at Clay's apartment and a .44 caliber bullet removed from her husband were all fired from the same weapon, the expert said.
Black was sentenced to two life terms for the murders of Angela Clay and Latoya, court records show. He received a death sentence for the murder of Lakeisha.
Bennie Clay, Angela's husband and the girls' father, declined to comment for this story.
Black's attorneys say he is very sick, describing him in a statement as a 'frail, wheelchair-bound man' suffering numerous health issues, including dementia and congestive heart failure. They are also seeking a stay of execution for reasons aside from his ICD, arguing he has an intellectual disability that should make him ineligible for execution under the Eighth Amendment.
Black's attorneys have also asked Gov. Bill Lee, a Republican, to grant him clemency, citing his disability, or to issue a reprieve so TDOC can find someone to deactivate his ICD.
Black received his implant in May 2024, court records indicate. The device includes both pacemaker and defibrillator functions: The pacemaker sends electrical impulses to Black's heart if his heart rate drops too low, while the defibrillator delivers more powerful shocks if his heart rate becomes too high.
'This type of shock is powerful, and people describe it as getting punched in the chest or kicked in the chest,' said Dr. Jonathan Groner, a professor emeritus of surgery at the Ohio State University College of Medicine, recalling a patient's description. Groner, who has been critical of the medicalization of capital punishment, emphasized he is not a cardiologist.
The implant can be deactivated in one of two ways, according to a ruling by Davidson County Chancery Court Chancellor Russell Perkins after a two-day hearing on Black's case last month: by placing a medical instrument or a magnet above the device from outside Black's body. Both methods require a trained medical professional, Perkins wrote.
In Black's case, the timing is key, according to his lawyers: If turned off too early, they argue the device will expose their client to the risk of suffering an arrhythmia, or irregular heartbeat, that might kill him while the courts are still considering his appeals and a ruling to delay the execution could be imminent.
According to Perkins' ruling, experts for the state testified the lethal injection drug, pentobarbital, would render Black unconscious, so he would not feel any shocks if they occurred. An expert for Black, however, argued the drug would only make him unresponsive, not unconscious, meaning he would feel the pain but be unable to respond.
'The state wants to say he'll be unconscious, but that's just not where the science is,' Henry said. 'The science tells us that he may not be able to respond, but he'll be experiencing everything.'
After hearing dueling expert testimony, Perkins ruled in Black's favor and ordered state officials to arrange for a medical professional to deactivate the implant at Black's execution.
Perkins later modified the order to allow the deactivation early Tuesday morning, after state officials said in a court filing doctors at Nashville General Hospital would not come to the execution chamber but were willing to do so a day earlier if Black were transported there.
The hospital, however, denies this, and the state acknowledged in court records last week there had been an error.
An assistant TDOC commissioner said she was told a medical vendor for the department had secured an appointment to deactivate Black's implant. The vendor later informed TDOC its legal team did not recommend any further involvement in Black's execution, the assistant commissioner said in a court filing.
When the assistant commissioner contacted Nashville General, her calls and voicemails were not returned, and the TDOC learned the hospital was unwilling to participate, the filing said.
Nashville General Hospital confirmed its refusal to cooperate in Black's execution, telling CNN in a statement that earlier reports suggesting otherwise were 'inaccurate.'
'NGH has no role in State executions,' the statement said. 'The correctional healthcare provider contracted by the Tennessee Department of Correction (TDOC), did not contact appropriate Nashville General Hospital leadership with its request to deactivate the implanted defibrillator. Any assertion the hospital would participate in the procedure was premature.'
'Our contract with the correctional healthcare provider is to support the ongoing medical care of its patients,' the statement added, describing the request to deactivate Black's device as 'well outside of that agreement.'
The Tennessee Supreme Court subsequently overruled Perkins' order, siding with the attorney general's office. The court agreed Perkins' order to deactivate Black's implant was effectively a stay of execution that exceeded the authority of the Davidson County Chancery Court.
The Tennessee Supreme Court added, 'Nothing in our decision today prevents the parties from reaching an agreement regarding deactivation of Mr. Black's ICD should it become feasible for the procedure to be performed at an appropriate time.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
24 minutes ago
- Yahoo
Raw milk sickens 21 people in Florida including 6 children
TALLAHASSEE, Fla. (AP) — Six children are among 21 people who have E. coli or campylobacter infections after consuming raw milk from a farm in Florida, public health officials said. Seven people have been hospitalized, and at least two of them are suffering severe complications, the Florida Department of Health said Monday. It did not specify if any of the six infected children under 10 are among those being treated in hospitals, nor how many people were infected by E. coli, campylobacter or both bacteria. 'Sanitation practices in this farm are of particular concern due to the number of cases,' reads the state advisory, which did not identify the farm linked to the cluster of infections in northeast and central Florida. Raw milk appears to be gaining in popularity, despite years of warnings about the health risks of drinking unpasteurized products. The Food and Drug Administration and the Centers for Disease Control and Prevention say raw milk is one of the 'riskiest' foods people can consume. Raw milk is far more likely than pasteurized milk to cause illnesses and hospitalizations because of dangerous bacteria such as campylobacter, listeria, salmonella and E. coli, research shows. The infections can cause gastrointestinal illness, and in some cases may lead to serious complications, including a life-threatening form of kidney failure. Young children, the elderly, immunocompromised people and pregnant women are at greater risk of complications. 'We invented pasteurization for a reason,' said Keith Schneider, a food safety professor at the University of Florida. 'It's maddening that this is happening.' States have widely varying regulations regarding raw milk, with some allowing retail purchases in stores and others allowing sale only at farms. Some states allow 'cowshares,' in which customers buy milk produced by designated animals, and some allow consumption only by farm owners, employees or 'non-paying guests.' In Florida, the sale and distribution of raw milk for human consumption is illegal, but retailers get around the ban by labeling their products as for pet or animal food only. Schneider called it a 'wink, wink, nudge, nudge,' form of regulation. 'Everybody knows that they're selling it for human consumption,' Schneider said, adding that people getting sick — or even seriously ill — from drinking raw milk is 'not a question of if, but when.' ___ Kate Payne is a corps member for The Associated Press/Report for America Statehouse News Initiative. Report for America is a nonprofit national service program that places journalists in local newsrooms to report on undercovered issues. Solve the daily Crossword


Fast Company
25 minutes ago
- Fast Company
Heartflow stock listing and IPO date draw near: AI-powered medtech aims for $1.3 billion valuation
It seems there's fresh blood pumping back into the IPO market. After a blowout initial public offering from Figma last week, investors might have another chance to get their heart rates up again soon. Heartflow, a California-based medtech company that utilizes AI with imaging and diagnostics software to help evaluate cardiac and coronary diseases, is looking to list shares on the Nasdaq. In paperwork filed on Friday with the Securities and Exchange Commission (SEC), Heartflow said it plans to offer 12.5 million shares, priced between $15 and $17. That could potentially raise more than $208 million. According to Reuters, Heartflow's target valuation could be as high as $1.3 billion. The company plans to trade under the ticker 'HTFL.' Subscribe to the Daily newsletter. Fast Company's trending stories delivered to you every day Privacy Policy | Fast Company Newsletters Personalized 3D-models of people's hearts Heartflow uses AI and other technology to scan patients for coronary and cardiac problems, creating three-dimensional models of patients' hearts. The Food and Drug Administration (FDA) gave the software the green light in 2022, and it's now being used in some markets to diagnose patients. Additionally, the company got a leg up last year when the U.S. Centers for Medicare and Medicaid Services (CMS) expanded Medicare coverage to include platforms that use imaging results to look for signs of coronary disease, and the American Medical Association (AMA) issued a new Category I CPT code for those platforms. That gives doctors and clinics the go-ahead to start using the technology on a broader scale starting next year. According to the company's SEC filing, Heartflow says that as of the end of March 2025, it's been used to assess more than 400,000 patients. Revenues are growing but profits are elusive Heartflow generated $125.8 million in 2024, a 44% increase over the $87.2 million it made the year before, the company says. Revenue likewise grew 39% for the first quarter of 2025 to $37.2 million. However, the company saw a net loss of $96.4 million in 2024, wider than its net loss of $95.7 million in 2023. It warns in the filing that it expects to incur 'substantial losses in the foreseeable future [and] may not be able to achieve or sustain profitability.' Bain Capital, Panorama Point Partners, and Capricorn Investment Group are among Heartflow's backers, according to Crunchbase. Bain led its most recent fundraising round, a Series F round in 2023, which raised $215 million. This is not the first time that Heartflow has attempted to go public. The company had planned to merge with a special purpose acquisition company during the SPAC frenzy of the early pandemic years, but it halted the plan in 2022, citing 'unfavorable market conditions,' as Fierce Biotech reported. Heartflow's IPO comes on the heels of another growing medtech company's public debut. Carlsmed, which specializes in AI-driven spine surgery technology, recently went public as well, with shares trading on July 23. Since then, the stock is down around 4.5%. Heartflow has not said when it plans to list its stock. Fast Company reached out for more details on the timeline and will update this post if we hear back.


Fox News
26 minutes ago
- Fox News
New study warns of plastics crisis threatening Americans' health
Fox News senior medical analyst Dr. Marc Siegel explains the risk of microplastics to human health.